RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

<<This implies they don't have definitive CX717 data to submit that will remove the cloud entirely from it. Meaning AD and not ADHD for CX717?>>

That is incorrect. They were working on CX701 as a backup before CX717 ever ran into clinical hold problems. Everyone wants a backup, either to include in a deal, or to develop inhouse for orphans. They can't be sure what the FDA is going to do or say, but that has nothing to do with wanting a backup in the clinic.They wanted and needed that no matter what.

NeuroInvestment